Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Oral Immunonutrition Therapy in Reducing Acute Toxicity After Neoadjuvant Chemoradiotherapy Among Pancreatic Cancer Patients: a Prospective, Single-arm Clinical Trial

NCT06736678 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06736678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06736678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Oral Immunonutrition Therapy in Reducing Acute Toxicity After Neoadjuvant Chemoradiotherapy Among Pancreatic Cancer Patients: a Prospective, Single-arm Clinical Trial
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Unknown status
Start date
August 26, 2024
Completion date
September 30, 2025
Enrollment
98 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunonutrition, neoadjuvant chemoradiotherapy, pancreatic cancer